CHRISTY MASSIE: Open Payments
NPI 1972858843 · ATHENS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,536 in 84 payments from 14 companies in 2025. Trend: 2023 $798 · 2024 $1,621 · 2025 $1,536
Food & beverage: $1,536
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $273 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $250 |
| Amgen Inc. | 12 | $192 |
| AstraZeneca Pharmaceuticals LP | 6 | $182 |
| Novo Nordisk Inc | 14 | $163 |
| Axsome Therapeutics, Inc. | 3 | $104 |
| Exact Sciences Corporation | 6 | $102 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $61 |
| Lilly USA, LLC | 4 | $58 |
Products named: Kerendia, VRAYLAR, OTEZLA, BREZTRI, Auvelity, XIFAXAN, The Cologuard Plus Collection Kit, CAPLYTA.
Industry payments across OH — which companies pay providers there.
